Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus esmolol for cardiac recovery after valve replacement surgery
PACTR201902822178026Completed
- Sponsor
- Menoufia University Hospitals
- Start
- Jan 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine, esmolol and Normal Saline-Benha University in Cardiac valve disease (VHD) (3 arms), sponsored by Menoufia University Hospitals. Primary endpoint: Recovery time. Started Jan 2017; status: completed.
02
Drugs
dexmedetomidineesmololNormal Saline-Benha University
03
Conditions
Cardiac valve disease (VHD)
Beyond the preview
Go deeper on PACTR201902822178026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201902822178026.